The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals
Open accessAbstract
Background: Little is known about the frequency, hospital-level variation, predictors, and outcomes of antibiotic de-escalation in suspected sepsis. Methods: We retrospectively analyzed adults admitted to 236 US hospitals from 2017–2021 with suspected sepsis (defined by blood culture draw, lactate measurement, and intravenous antibiotic administration) who were initially treated with ≥2 days of anti–methicillin-resistant Staphylococcus aureus (MRSA) and anti-pseudomonal antibiotics but had no resistant organisms that required these agents identified through hospital day 4. De-escalation was defined as stopping anti-MRSA and anti-pseudomonal antibiotics or switching to narrower antibiotics by day 4. We created a propensity score for de-escalation using 82 hospital and clinical variables; matched de-escalated to non–de-escalated patients; and assessed associations between de-escalation and outcomes. Results: Among 124 577 patients, antibiotics were de-escalated in 36 806 (29.5%): narrowing in 27 177 (21.8%), cessation in 9629 (7.7%). De-escalation rates varied between hospitals (median, 29.4%; interquartile range, 21.3%–38.0%). Predictors of de-escalation included less severe disease on day 3–4, positive cultures for nonresistant organisms, and negative/absent MRSA nasal swabs. De-escalation was more common in medium, large, and teaching hospitals in the Northeast and Midwest. De-escalation was associated with lower adjusted risks for acute kidney injury (AKI) (odds ratio [OR], 0.80; 95% confidence interval [CI], .76–.84), intensive-care unit (ICU) admission after day 4 (OR, 0.59; 95% CI, .52–.66), and in-hospital mortality (OR, 0.92; 95% CI, .86–.996). Conclusions: Antibiotic de-escalation in suspected sepsis is infrequent, variable across hospitals, linked with clinical and microbiologic factors, and associated with lower risk for AKI, ICU admission, and in-hospital mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“de-escalation remains variable”
From Day-4 antipseudomonal and anti-MRSA de-escalation was not associated with higher mortality in critically ill patients with sepsis (2026) · cites this paper as [3]
In the citing paper
“resistant pathogens are identified in only a minority of patients initially receiving broad coverage (3–5).”
From Day-4 antipseudomonal and anti-MRSA de-escalation was not associated with higher mortality in critically ill patients with sepsis (2026) · cites this paper as [3]
In the citing paper
“Empiric anti-MRSA and antipseudomonal therapy are common”
From Day-4 antipseudomonal and anti-MRSA de-escalation was not associated with higher mortality in critically ill patients with sepsis (2026) · cites this paper as [3]
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationFlexible Imputation of Missing Data, Second Edition
van Buuren, S. (2018) · doi:10.1201/9780429492259 · Cited by 2,273
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Rhee, C., Jones, T. M., Hamad, Y., Pande, A., Varon, J., O’Brien, C., Anderson, D. J., Warren, D. K., Dantes, R. B., Epstein, L., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7571 · Cited by 584
Self-citationRhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., Klompas, M., & Program, F. T. C. P. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2899 · Cited by 397
Self-citationGarnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389
The gut microbiome’s role in the development, maintenance, and outcomes of sepsis
Adelman, M. W., Woodworth, M. H., Langelier, C., Busch, L. M., Kempker, J. A., Kraft, C. S., & Martin, G. S. (2020) · Critical Care · doi:10.1186/s13054-020-02989-1 · Cited by 342
Bai, A. D., Showler, A., Burry, L., Steinberg, M., Ricciuto, D. R., Fernandes, T., Chiu, A., Raybardhan, S., Science, M., Fernando, E., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ120 · Cited by 254
Cited by
Shappell, C. N., Yu, T., Klompas, M., Agan, A. A., DelloStritto, L. K., Faine, B. A., Filbin, M. R., Mohr, N. M., Park, S. T., Plechot, K., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf118 · Cited by 31
Self-citationNational Estimates of Pediatric Sepsis in US Hospitals Using Clinical Data
Rhee, C., Balamuth, F., Dysart, K., Miller, E., Li, Z., Huang, J., Gunturi, D., Ostapenko, S., Jin, R., DelloStritto, L. K., et al. (2026) · JAMA · doi:10.1001/jama.2026.3100 · Cited by 26
Self-citationOptimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11
Farsani, A., Thandi, P., & Htway, Z. (2025) · Cureus · doi:10.7759/cureus.90728 · Cited by 6
Gupta, S., Klompas, M., McKenna, C. S., Agan, A. A., DelloStritto, L. K., Kalil, A. C., & Rhee, C. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag401 · Cited by 6
Self-citation
Metadata
- Authors
- Kam, K. Q., Chen, T., Kadri, S. S., Lawandi, A., Yek, C., Walker, M., Warner, S., Fram, D., Chen, H.-C., Shappell, C. N., DelloStritto, L., Jin, R., Klompas, M., & Rhee, C.
- Affiliations
- SingHealth (SG)
- Harvard Pilgrim Health Care (US)
- National Institutes of Health (US)
- Commonwealth Informatics , Waltham, Massachusetts ,
- Brigham and Women's Hospital (US)
- Corresponding author
- Kam, Kai Qian
- Rhee, Chanu
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-12-06
- Volume
- 80
- Issue
- 1
- Pages
- 108-117
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC11797381
- OpenAlex
- W4405224960
- Cited by
- 29
- References
- 38
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 1
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (U54CK000611)
- Agency for Healthcare Research and Quality (K08HS029518)
- National Institutes of Health Clinical Center
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- antibiotic de-escalation, suspected sepsis, methicillin-resistant Staphylococcus aureus, hospital-level variation, acute kidney injury, intensive care unit admission, in-hospital mortality, antibiotic stewardship, MRSA nasal carriage, propensity score matching
- MeSH terms
- Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Female, Hospitals, Humans, Male, Middle Aged, Retrospective Studies, Staphylococcal Infections, United States, Treatment Outcome, Hospital Mortality, Sepsis, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals. https://app.cochat.ai/papers/10.1093/cid/ciae591
- The paper
- Kam, K. Q., Chen, T., Kadri, S. S., Lawandi, A., Yek, C., Walker, M., Warner, S., Fram, D., Chen, H.-C., Shappell, C. N., DelloStritto, L., Jin, R., Klompas, M., & Rhee, C. (2025). Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae591
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.